| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/30/2013 | US8431589 2,4-diaminopyrimidine derivatives |
| 04/30/2013 | US8431579 Capped pyrazinoylguanidine sodium channel blockers |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431573 Cyanopyrimidinones |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/30/2013 | CA2517256C Aminoheteroaryl compounds as protein kinase inhibitors |
| 04/25/2013 | WO2013059433A2 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
| 04/25/2013 | WO2013059281A2 Processes for the preparation of novel benzimidazole derivatives |
| 04/25/2013 | WO2013058361A1 Crystals of androgen receptor antagonist compound |
| 04/25/2013 | WO2013058343A1 Organic electroluminescence element and material for organic electroluminescence element |
| 04/25/2013 | WO2013058258A1 Bicyclic heterocyclic compound |
| 04/25/2013 | WO2013058256A1 Nitrogenated heterocyclic compound, and bactericidal agent for agricultural and horticultural purposes |
| 04/25/2013 | WO2013057711A1 Quinazoline derivatives as pi3k modulators |
| 04/25/2013 | WO2013057545A1 Acid addition salts of bosentan |
| 04/25/2013 | WO2013056679A1 Novel heteroaryl-amino derivatives |
| 04/25/2013 | WO2012174487A3 Bromodomain inhibitors and uses thereof |
| 04/25/2013 | WO2012174164A3 Agonists of gpr131 and uses thereof |
| 04/25/2013 | WO2012037928A3 Compounds for the diagnosis of neurodegenerative disorders on the olfactory epithelium |
| 04/25/2013 | US20130102788 Method for Synthesizing 1,3,5-Tri-(N-Phenylbenzimidazolyl) Benzene |
| 04/25/2013 | US20130102629 Analogues for the treatment or prevention of flavivirus infections |
| 04/25/2013 | US20130102622 Novel Quinazoline-2,4-Dione Derivative, and Medical Compositions for the Prophylaxis and Treatment of Cranial Nerve Disease Containing the Same |
| 04/25/2013 | US20130102618 3-amino-5,6-dihydro-1h-pyrazin-2-one derivatives useful for the treatment of alzheimer's disease and other forms of dementia |
| 04/25/2013 | US20130102615 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors |
| 04/25/2013 | US20130102607 Ureido-pyrazole derivatives for use in the treatment of rhinovirus infections |
| 04/25/2013 | US20130102604 Novel cyclopropane indolinone derivatives |
| 04/25/2013 | US20130102602 2-Aryl-4-Quinazolinones And Their Pharmaceutical Compositions |
| 04/25/2013 | US20130102592 Oxazole tyrosine kinase inhibitors |
| 04/25/2013 | US20130102585 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 04/25/2013 | US20130102568 Alkoxyimino derivative and pest control agent |
| 04/25/2013 | US20130099171 Materials for organic electroluminescent devices |
| 04/25/2013 | CA2852900A1 Processes for the preparation of novel benzimidazole derivatives |
| 04/25/2013 | CA2852830A1 Acid addition salts of bosentan |
| 04/25/2013 | CA2852682A1 Hybrid diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer |
| 04/25/2013 | CA2851589A1 Bicyclic heterocyclic compound |
| 04/24/2013 | EP2582695A1 Anthranilic acid diamide derivatives with cyclical side chains |
| 04/24/2013 | EP2582692A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 04/24/2013 | EP2582691A1 Anthranilic acid derivatives |
| 04/24/2013 | EP2582680A1 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| 04/24/2013 | EP2582672A1 X-ray and gamma-photon activable organic compounds, their preparation and their uses |
| 04/24/2013 | EP2582668A1 Carboline carboxamide compounds useful as kinase inhibitors |
| 04/24/2013 | EP2582432A1 Ureido-pyrazole derivatives for use in the treatment of respiratory syncitial virus (rsv) infection |
| 04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 04/24/2013 | CN103068821A 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors |
| 04/24/2013 | CN103068819A Heterocyclic antiviral compounds |
| 04/24/2013 | CN103068817A Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin b1 receptor |
| 04/24/2013 | CN103068814A 邻氨基苯甲酸衍生物 Anthranilic acid derivatives |
| 04/24/2013 | CN103068806A 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 04/24/2013 | CN103068798A Di-azetidinyl diamide as monoacylglycerol lipase inhibitors |
| 04/24/2013 | CN103068797A Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application |
| 04/24/2013 | CN103059272A Hyperbranched conjugated polymer and preparation method and application thereof |
| 04/24/2013 | CN103059014A Novel heteroaryl amino derivative |
| 04/24/2013 | CN103059003A Benzimidazole-1,2,3-triazole compound having antifungal activity, and its preparation method |
| 04/24/2013 | CN103059002A Pyrimidine derivative with Aurora kinase inhibitory activity and preparation method and application thereof |
| 04/24/2013 | CN103059001A Quinazolinone Schiff base containing triazole and preparation method thereof |
| 04/24/2013 | CN103058939A Heterocyclic compound and organic light-emitting device containing the same |
| 04/24/2013 | CN101993435B Triazole ring and ether bond-containing maleimide, and preparation method and use of resin thereof |
| 04/24/2013 | CN101993434B Acetylenyl terminated triazole imide low polymer and preparation method thereof |
| 04/24/2013 | CN101993433B Olmesartan organic amine salt, preparation method and application thereof |
| 04/24/2013 | CN101522644B Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 04/24/2013 | CN101472584B Indoles and benzoimidazoles as histamine H4 receptor modulators |
| 04/23/2013 | US8426585 Compounds comprising a spiro-ring |
| 04/23/2013 | US8426458 Hepatitis C Virus inhibitors |
| 04/23/2013 | US8426426 Gyrase inhibitors and uses thereof |
| 04/23/2013 | US8426425 Aminopyrimidines useful as inhibitors of protein kinases |
| 04/23/2013 | US8426424 Certain substituted amides, method of making, and method of use thereof |
| 04/23/2013 | US8426420 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists |
| 04/23/2013 | US8426419 Tyrosine kinase inhibitors containing a zinc binding moiety |
| 04/23/2013 | US8426417 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 04/23/2013 | US8426412 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides |
| 04/23/2013 | US8426409 7-tert-Butyl-3-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-3H-quinazolin-4-one; arthritis; inhibit Btk |
| 04/23/2013 | US8426408 Pyrimidine inhibitors of kinases |
| 04/23/2013 | US8426400 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists |
| 04/23/2013 | US8425891 UV-absorbers for ophthalmic lens materials |
| 04/23/2013 | CA2697081C 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors |
| 04/23/2013 | CA2610042C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/23/2013 | CA2548276C Keto lactam compounds and use thereof |
| 04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
| 04/18/2013 | WO2013056142A2 Meso-biliverdin compositions and methods |
| 04/18/2013 | WO2013056015A1 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
| 04/18/2013 | WO2013055984A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013055949A2 Pyrazol-3-ones that activate pro-apoptotic bax |
| 04/18/2013 | WO2013055825A2 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/18/2013 | WO2013055793A1 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer |
| 04/18/2013 | WO2013054338A1 2-thio-imidazole derivatives as tgr5 modulators |
| 04/18/2013 | WO2013054108A1 Mono-fluoro beta-secretase inhibitors |
| 04/18/2013 | WO2013053983A1 Protein kinase inhibitors |
| 04/18/2013 | WO2013053206A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof |
| 04/18/2013 | WO2013053051A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096301 Kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | US20130096145 Use of 1H-quinazoline-2,4-diones |
| 04/18/2013 | US20130096144 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096101 Inhibitors of hcv ns5a |
| 04/18/2013 | US20130095322 Novel yellow pigment composition, and method for producing yellow pigment microparticles |
| 04/18/2013 | US20130095035 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
| 04/18/2013 | US20130092903 Heterocyclic compound and organic light-emitting device containing the same |
| 04/18/2013 | CA2851788A1 Pyrazol-3-ones that activate pro-apoptotic bax |
| 04/18/2013 | CA2851516A1 Guanidinyl-substituted polyamides useful for treating human papilloma virus |
| 04/18/2013 | CA2850394A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |